Peptilex
Study tracker · Metabolism · Mitochondria

MOTS-c

Updated 19 Oct 2026 · Peptilex evidence grade D (A = approved, large trials · D = mainly animal studies)

A peptide encoded in mitochondrial DNA, discovered in 2015. In mice it prevented diet-induced obesity and insulin resistance; a modified analogue (CB4211) completed a randomized phase 1a/1b trial with 88 participants.
264PubMed papers
152Human studies
4Randomized trials
2Registered studies
1Ongoing / starting
0Phase 3+

Registered trials

From ClinicalTrials.gov, matched by name in the study title.

StudyPhaseStatusParticipantsStart
Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal Transplantation
NCT07678073 · University of Gaziantep
–Recruiting682026-03
Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD
NCT04027712 · University of Athens
ObservationalStatus unknown1202014-01

1 further registry entry from a sponsor we could not verify is not listed.

Latest randomized trials & key papers

From PubMed. The full story – mechanism, all results, risks – is in the MOTS-c profile of the book.

Peptilex – The Peptide Encyclopedia, book cover

34 peptides. One book.

A science-based guide for beginners to 34 peptides: what each one does, the most exciting research results, and where it stands in 2026. Every profile: what it is, the most exciting results, key studies, risks and open questions.

KindlePaperbackHardcover